Soros Fund Management’s DexCom DXCM Stock Holding History

Soros Fund Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-166,800	Closed	-$18.9M	–	199
2024 Q2	$18.9M	Buy	166,800 +116,800	+234%	+$14.8M	0.34%	76
2024 Q1	$6.93M	Sell	50,000 -60,000	-55%	-$7.54M	0.12%	132
2023 Q4	$13.6M	Sell	110,000 -75,000	-41%	-$7.66M	0.18%	120
2023 Q3	$17.3M	Buy	+185,000	New	+$20.9M	0.24%	97
2018 Q1	–	Sell	-15,200	Closed	-$218K	–	239
2017 Q4	$218K	Buy	+15,200	New	+$198K	0.01%	190
2017 Q2	–	Sell	-11,200	Closed	-$237K	–	236
2017 Q1	$237K	Sell	11,200 -10,000	-47%	-$195K	﹤0.01%	234
2016 Q4	$316K	Buy	21,200 +10,896	+106%	+$193K	0.01%	173
2016 Q3	$226K	Buy	+10,304	New	+$229K	0.01%	214
2016 Q1	–	Sell	-22,800	Closed	-$467K	–	255
2015 Q4	$467K	Buy	+22,800	New	+$474K	0.01%	191
2013 Q3	–	Sell	-400,000	Closed	-$2.25M	–	241
2013 Q2	$2.25M	Buy	+400,000	New	+$1.92M	0.02%	180

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Soros Fund Management's DXCM Position: Q3 2024 in Review

Soros Fund Management sold out of DexCom (DXCM) in Q3 2024, closing a stake of 166,800 shares — an estimated $18.9M sold.

Soros Fund Management first reported a position in DXCM in Q2 2013 and held it in 10 quarters. The position peaked at $18.9M in Q2 2024. 890 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

Soros Fund Management reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
Soros Fund Management sold 166,800 DexCom shares in Q3 2024, an estimated $18.9M.
Soros Fund Management first reported a position in DexCom in Q2 2013 and held it in 10 quarters.
Soros Fund Management's DexCom position peaked at $18.9M in Q2 2024.
890 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on Soros Fund Management's 13F filing for Q3 2024, filed 14 Nov 2024.